SPRB · Spruce Biosciences, Inc.
$42.28
-2.71 (-6.02%)
At close · Jul 24
Market Cap
$118.57M
Shares
2.75M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
-100%
FY2025
Net Income
-$38.97M
+26.5%
FY2025
Operating Margin
-1143.37%
-628pp
FY2024
Diluted EPS
-$50.83
+47.3%
FY2025
Operating Cash Flow
-$33.33M
+40.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| — | $0 | $4.91M | $10.09M | $0 | — | — | — | |
| $16.26M | $19.52M | $46.42M | $49.43M | $35.2M | $30.7M | $23.85M | $10.82M | |
| $17.75M | $16.99M | $14.64M | $12.65M | $12.09M | $11.37M | $5.56M | $2.29M | |
| — | $21K | $46K | $70K | $74K | $68K | $36K | $12K | |
| $34.01M | $36.51M | $61.06M | $62.08M | $47.28M | $42.07M | $29.42M | $13.11M | |
| -$34.01M | -$36.51M | -$56.15M | -$51.99M | -$47.28M | -$42.07M | -$29.42M | -$13.11M | |
| — | — | -1143.37% | -515.34% | — | — | — | — | |
| — | -$36.49M | -$56.11M | -$51.92M | -$47.21M | -$42M | -$29.38M | -$13.1M | |
| $728K | $90K | $307K | $483K | $420K | $345K | $323K | $65K | |
| — | — | — | — | — | $119K | $200K | $84K | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| -$37.19M | -$38.97M | -$53.04M | -$47.92M | -$46.18M | -$42.29M | -$29.54M | -$13.09M | |
| — | — | -1079.94% | -474.96% | — | — | — | — | |
| — | — | -$53.04M | -$47.36M | -$46.55M | -$42.48M | -$29.54M | — | |
| USD/shares | — | -$50.83 | -$96.40 | -$6,975.00 | -$11,025.00 | -$10,181.25 | — | — |
| USD/shares | — | -$50.83 | -$96.40 | -$6,975.00 | -$11,025.00 | -$10,181.25 | — | — |
| shares | — | 766.6K | 550.15K | 6846.2613 | 4182.5984 | 4153.1406 | 1065.1045 | 135.8948 |
| shares | — | 766.6K | 550.15K | 6846.2613 | 4182.5984 | 4153.1406 | 1065.1045 | 135.8948 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.41×
EV/EBIT
—
Biotechnology median 26.60×
P/E (TTM)
—
Biotechnology median 7.07×